Signalling inhibition by ponatinib disrupts alternative lengthening of telomeres (ALT)

ABSTRACT: Analyses of gene expression changes in cells treated with ponatinib (experiment 1), and in cells either lacking JUN or overexpressing JUN (experiment 2).

ORGANISM(S): Homo sapiens

PROVIDER: GSE190438 | GEO | 2023/01/30

REPOSITORIES: GEO